(-)-epigallocatechin 3-gallate/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases body mass
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×3“By contrast high fat-fed mice treated with EGCG showed a 21.7% reduction in the rate of body weight gain and a 9.4% decrease in final body weight (p < 0.05, Table 1).”
Quoted verbatim from (-)-Epigallocatechin-3-gallate increases the expression of genes related to fat oxidation in the skeletal muscle of high fat-fed mice.. - Study
- animal · not in humans
- Duration
- 4 months
- Dose
- 0.32% EGCG in the diet
- Population
- High-fat-fed C57bl/6J mice given 0.32% EGCG in the diet for 16 weeks versus high-fat-fed mice without EGCG; final body weight
(-)-Epigallocatechin-3-gallate increases the expression of genes related to fat oxidation in the skeletal muscle of high fat-fed mice.2011PMID:21779555Permalink
Keep reading
- Everything the graph holds on (-)-epigallocatechin 3-gallate
- Every compound studied against Body mass
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45SNP88C7QKP53Q1ASWT3FK